DJIA 17,949.59 -85.34 -0.47%
NASDAQ 5,014.10 19.50 0.39%
S&P 500 2,097.29 -3.11 -0.15%
market minute promo

Pfizer (NYSE: PFE)



company name or ticker

Merck KGaA-Pfizer Start First Cancer Registration Study - Analyst Blog

Roche Earnings Preview: Cancer Drug Growth Will Be Offset By Legacy Declines And Adverse Currency Mo

Roche Earnings Preview: Cancer Drug Growth Will Be Offset By Legacy Declines And Adverse Currency Movement

Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed

Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

After Hours Most Active for Apr 20, 2015 : AU, WY, PFE, QQQ, ABEV, WBA, GLW, EMC, SGYP, MSFT, FOXA,

After Hours Most Active for Apr 20, 2015 : AU, WY, PFE, QQQ, ABEV, WBA, GLW, EMC, SGYP, MSFT, FOXA, INTC

iShares Core S&P 500 ETF Experiences Big Inflow

Global & Strategic Partners Initiate Phase III Study with Avelumab in Patients with Stage IIIb/IV No

Global & Strategic Partners Initiate Phase III Study with Avelumab in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer

3 Megatrends in Healthcare

These three megatrends could be largely responsible for value creation and the impetus for innovation within the healthcare sector throughout the remainder of the decade.

These Companies Probably Won't Be Acquiring Ariad Pharmaceuticals

Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog

Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog

See More Articles...